Achieving Significant Savings with WellDyne Clear
The traditional PBM model is complex. Value is promised through guaranteed discounts off list prices and guaranteed rebates without direct focus on total cost. As a result, PBMs are meeting guarantees while costs continue to rise. This leaves plans to search for cost efficiencies in a sea of homogenous, opaque pricing solutions. WellDyne brings unparalleled transparency to an industry in need.
A mid-sized employer with 2,400 members, previously managed by a Big 3 PBM, was frustrated with the complex and opaque pricing models. They sought greater transparency and control over their pharmacy spend, aiming to reduce overall plan costs without compromising the quality of care for their members.
Delivering Clear Value
WellDyne Clear takes a distinctive approach, offering a model that is simple and resolves the conflicts of interest in traditional PBM agreements, freeing WellDyne to focus on delivering enhanced value at lower net cost. The innovative, transparent solution yielded 17% PMPM savings over a traditional offering through:
Lowest Net Cost Methodology
WellDyne focuses on net cost instead of high rebates—bringing the best drug at the lowest cost to the member. Utilization management strategies and strict adherence to evidence-based prior authorization criteria ensure appropriate use to help contain costs. By shifting drug utilization from high-cost brands with rebates to the lowest net-cost product, WellDyne effectively reduced the plan’s overall drug spend.
Innovative Cost Containment Strategies
Once the formulary was optimized, WellDyne implemented additional value-driven solutions to maximize savings and improve patient outcomes. These included:
- Identifying the best price in the market through various channels—international sourcing, manufacturer copay assistance, Mark Cuban Cost Plus Drug Company and others.
- Utilizing an integrated ecosystem and cutting-edge technologies to guide effortless transitions to the most cost-effective product or channel.
- Deploying advanced solutions targeting specialty and chronic conditions, which eliminated waste, increased adherence and closed gaps in care to control drug spend.
WellDyne can bring a truly transparent cost-plus offering to life, as the enterprise owns its pharmacy contracts and dispensing assets. Reselling rented networks and third-party dispensing, as many PBMs do, is just putting a new gloss on the old-fashioned list-price-discount deals. WellDyne brought to this client true cost-plus transparency and a singular focus on a PMPM net spend guarantee. By removing the complexity of traditional models, there was no room for poor performance to hide. WellDyne Clear prioritized low-cost, first-line therapies and optimized delivery channels to provide the highest quality care at significant savings. When visibility matters, the choice is Clear.
